Lewis Sanders
Sanders Capital
Lewis Sanders Novartis AG ADR stake
total: 132
Sanders Capital NVS trades
- Total transactions:
- 13
- New positions:
- 2
- Sold out:
- 2
- Added:
- 3
- Reduced:
- 6
- Held since:
- 2022 Q1
- Held for:
- 7 quarters
- Latest activity:
- 2023 Q4
According to 2026 Q2 report, Lewis Sanders doesn't hold any Novartis AG ADR (NVS) shares. Sanders Capital has held NVS since at least 2013 Q2 with 4,400 shares in our earliest available record. Lewis Sanders later completely sold out the position and invested in Novartis AG ADR again in 2022 Q1. Since at least 2013 Q2, Sanders Capital has made 12 more transactions.
When did Lewis Sanders sell Novartis AG ADR (NVS)?
Lewis Sanders sold off the entire Novartis AG ADR (NVS) position in 2023 Q4.
Estimated cost basis*
- Weighted AVG buy price:
- $87.76
- Weighted AVG sell price:
- $96.65
Lewis Sanders's historical trades in Novartis AG ADR
13 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2023 Q4
|
0.00%
|
0
|
$96.50
|
|
-100% (-1,073,420)
|
-0.22%
|
|
2023 Q3
|
0.22%
|
1,073,420
|
$96.50
|
$103,585,459
|
+0.07% (+710)
|
+0%
|
|
2023 Q2
|
0.23%
|
1,072,710
|
$100.91
|
$108,247,166
|
-5.11% (-57,820)
|
-0.01%
|
|
2023 Q1
|
0.25%
|
1,130,530
|
$92.00
|
$104,008,760
|
+0.06% (+670)
|
+0%
|
|
2022 Q4
|
0.27%
|
1,129,860
|
$90.72
|
$102,500,899
|
-0.16% (-1,820)
|
-0%
|
|
2022 Q3
|
0.24%
|
1,131,680
|
$76.01
|
$86,019,000
|
-0.15% (-1,740)
|
-0%
|
|
2022 Q2
|
0.24%
|
1,133,420
|
$84.53
|
$95,808,000
|
-0.28% (-3,220)
|
-0%
|
|
2022 Q1
|
0.22%
|
1,136,640
|
$87.75
|
$99,740,000
|
new
|
+0.22%
|
|
2016 Q4
|
0.00%
|
$78.95
|
-100% (-1,900)
|
|||
|
2016 Q3
|
0.00%
|
$78.95
|
-47.22% (-1,700)
|
|||
|
2016 Q2
|
0.00%
|
$82.50
|
-20.00% (-900)
|
|||
|
2014 Q2
|
0.00%
|
$90.44
|
+2.27% (+100)
|
|||
|
2013 Q2
|
0.00%
|
$70.68
|
new or own*
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.